{"name":"Prism Pharmaceuticals","permalink":"prism-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/prism-pharmaceuticals","homepage_url":"http://www.prismpharma.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@prismpharma.com","phone_number":"(610) 265-7710","description":"","created_at":"Tue Apr 19 03:15:57 UTC 2011","updated_at":"Tue Apr 19 03:15:57 UTC 2011","overview":"<p>Prism Pharmaceuticals, Inc., an acute care pharmaceutical company, engages in developing and commercializing cardiovascular injectable products in the United States. Its products include NEXTERONE, an anti arrhythmic agent in the form of injectable amiodarone; and PM103, an intravenous formulation of clopidogrel bisulfate. The company was founded in 2004 and is based in King of Prussia, Pennsylvania.</p>","image":{"available_sizes":[[[150,38],"assets/images/resized/0013/1096/131096v1-max-150x150.png"],[[240,62],"assets/images/resized/0013/1096/131096v1-max-250x250.png"],[[240,62],"assets/images/resized/0013/1096/131096v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President and CEO","person":{"first_name":"Warren","last_name":"D. Cooper","permalink":"warren-d-cooper","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":{"price_amount":338000000,"price_currency_code":"USD","term_code":"cash_and_stock","source_url":"http://www.fiercebiotech.com/story/baxter-nabs-prisms-arrythmia-drug-338m-buyout/2011-04-18?utm_medium=rss&utm_source=rss","source_description":"Baxter nabs Prism's arrythmia drug in $338M buyout ","acquired_year":2011,"acquired_month":4,"acquired_day":18,"acquiring_company":{"name":"Baxter International","permalink":"baxter-international","image":{"available_sizes":[[[150,60],"assets/images/resized/0007/8866/78866v1-max-150x150.png"],[[162,65],"assets/images/resized/0007/8866/78866v1-max-250x250.png"],[[162,65],"assets/images/resized/0007/8866/78866v1-max-450x450.png"]],"attribution":null}}},"acquisitions":[],"offices":[{"description":"","address1":"1016 West Ninth Avenue","address2":"Suite 130","zip_code":"19406","city":"King of Prussia","state_code":"PA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}